238 related articles for article (PubMed ID: 36911087)
1. Neurodegenerative disorders: Assessing the impact of natural vs drug-induced treatment options.
Mathur S; Gawas C; Ahmad IZ; Wani M; Tabassum H
Aging Med (Milton); 2023 Mar; 6(1):82-97. PubMed ID: 36911087
[TBL] [Abstract][Full Text] [Related]
2. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
3. Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics.
Sharifi-Rad M; Lankatillake C; Dias DA; Docea AO; Mahomoodally MF; Lobine D; Chazot PL; Kurt B; Tumer TB; Moreira AC; Sharopov F; Martorell M; Martins N; Cho WC; Calina D; Sharifi-Rad J
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32276438
[TBL] [Abstract][Full Text] [Related]
4. Herbal and Holistic Solutions for Neurodegenerative and Depressive Disorders: Leads from Ayurveda.
Sharma R; Kabra A; Rao MM; Prajapati PK
Curr Pharm Des; 2018; 24(22):2597-2608. PubMed ID: 30147009
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials.
Andrade S; Nunes D; Dabur M; Ramalho MJ; Pereira MC; Loureiro JA
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678841
[TBL] [Abstract][Full Text] [Related]
6. In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
Gnanaraj C; Sekar M; Fuloria S; Swain SS; Gan SH; Chidambaram K; Rani NNIM; Balan T; Stephenie S; Lum PT; Jeyabalan S; Begum MY; Chandramohan V; Thangavelu L; Subramaniyan V; Fuloria NK
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566187
[TBL] [Abstract][Full Text] [Related]
7. Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders.
Behl T; Makkar R; Sehgal A; Sharma N; Singh S; Albratty M; Najmi A; Meraya AM; Bungau SG
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956919
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's Disease: A Current Perspectives on Parkinson's Disease and Key Bioactive Natural Compounds as Future Potential Drug Candidates.
Ali N; Syeda A; Topgyal T; Gaur N; Islam A
Curr Drug Targets; 2022; 23(1):2-20. PubMed ID: 34165406
[TBL] [Abstract][Full Text] [Related]
9. Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders.
Pagonabarraga J; Álamo C; Castellanos M; Díaz S; Manzano S
Brain Sci; 2023 Feb; 13(2):. PubMed ID: 36831861
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Natural Compounds in Neurodegenerative Disorders.
Srivastava P; Yadav RS
Adv Neurobiol; 2016; 12():107-23. PubMed ID: 27651251
[TBL] [Abstract][Full Text] [Related]
12. Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients.
Tuzimski T; Petruczynik A
Molecules; 2022 May; 27(10):. PubMed ID: 35630702
[TBL] [Abstract][Full Text] [Related]
13. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
[TBL] [Abstract][Full Text] [Related]
14. Neuropharmaceutical Properties of Naringin Against Alzheimer's and Parkinson's Diseases: Naringin Protection Against AD and PD.
Poudineh M; Ghotbi T; Azizi F; Karami N; Zolfaghari Z; Gheisari F; Hormozi M; Poudineh S
Galen Med J; 2022; 11():e2337. PubMed ID: 36698693
[TBL] [Abstract][Full Text] [Related]
15. Application of
Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R
Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002
[TBL] [Abstract][Full Text] [Related]
16. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of carvacrol against Alzheimer's disease and other neurodegenerative diseases: A review.
Azizi Z; Majlessi N; Choopani S; Naghdi N
Avicenna J Phytomed; 2022; 12(4):371-387. PubMed ID: 35782773
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological exploration of traditional plants for the treatment of neurodegenerative disorders.
Wahid M; Ali A; Saqib F; Aleem A; Bibi S; Afzal K; Ali A; Baig A; Khan SA; Bin Asad MHH
Phytother Res; 2020 Dec; 34(12):3089-3112. PubMed ID: 32478964
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
